Large-scale testing (Phase 3)Study completedNCT02101788
What this trial is testing
Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer
Who this might be right for
Borderline Ovarian Serous TumorMicropapillary Serous CarcinomaOvarian Serous Adenocarcinoma+3 more
National Cancer Institute (NCI) 260